Safety and Immunogenicity of a Single-Shot Live-Attenuated Chikungunya Vaccine: A Double-blind, Multicentre, Randomised, Placebo-Controlled, Phase 3 Trial
Schneider M, Narciso-Abraham M, Hadl S, et al. Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet. 2023;401(10394):2138-2147. PMID: 37321235.
Abstrak
(Konten ini khusus untuk dokter. Registrasi untuk baca selengkapnya)